International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 3-8 , 1 May 2010

Mature Results of a Randomized Trial of Accelerated Hyperfractionated Versus Conventional Radiotherapy in Head-and-Neck Cancer

  • Michele I. Saunders, M.D.

      Affiliations

    • Marie Curie Research Wing, Mount Vernon Hospital, Northwood, United Kingdom
    • Academic Department of Oncology, University College Hospital, London, United Kingdom
    • ,
  • Ana M. Rojas, Ph.D.

      Affiliations

    • Marie Curie Research Wing, Mount Vernon Hospital, Northwood, United Kingdom
    • Corresponding Author InformationReprint requests to: Ana M. Rojas, Ph.D., Marie Curie Research Wing, Mount Vernon Hospital, Northwood, Middlesex, HA6 2RN, United Kingdom. Tel: (+44) 1923 844 638; Fax: (+44) 1923 844 840
    • ,
  • Mahesh K.B. Parmar, Ph.D.

      Affiliations

    • Medical Research Council Clinical Trials Office, London, United Kingdom
    • ,
  • Stanley Dische, M.D.

      Affiliations

    • Marie Curie Research Wing, Mount Vernon Hospital, Northwood, United Kingdom
    • ,
  • CHART Trial Collaborators

Received 18 February 2009 ,Revised 21 April 2009 ,Accepted 24 April 2009.

References 

  1. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949–955
  2. Pignon JP, le Maitre A, Bourhis J. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An update. Int J Radiat Oncol Biol Phys. 2007;69:S112–S114
  3. Bentzen SM, Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol. 2007;25:4096–4103
  4. Peters LJ. Changes in radiotherapeutic management of head and neck cancer: A 30-year perspective. Int J Radiat Oncol Biol Phys. 2007;69:S8–S11
  5. Dische S, Saunders M, Barrett A, et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 1997;44:123–136
  6. Saunders M, Rojas AM, Dische S. CHART revisited: A conservative approach for advanced head and neck cancer. Clin Oncol (R Coll Radiol). 2008;20:127–133
  7. Dische S, Warburton MF, Jones D, et al. The recording of morbidity related to radiotherapy. Radiother Oncol. 1989;16:103–108
  8. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163–170
  10. Cox DR. Regression models and life-tables. J R Stat Soc B. 1972;34:178–220
  11. Ang KK, Berkey BA, Pajak TF, et al. In response to Drs. Dubben, Beck-Bornholdt, and Llogie. Int J Radiat Oncol Biol Phys. 2002;52:1148–1150
  12. Trotti A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys. 2000;47:1–12
  13. Bourhis J, Lapeyre M, Tortochaux J, et al. Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: A GORTEC trial. J Clin Oncol. 2006;24:2873–2878
  14. Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial. Radiother Oncol. 1997;44:111–121
  15. Poulsen MG, Denham JW, Peters LJ, et al. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: A Trans-Tasman Radiation Oncology Group Study. Radiother Oncol. 2001;60:113–122
  16. Trotti A, Fu KK, Pajak TF, et al. Long term outcomes of RTOG 90-03: A comparison of hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:S70–S71
  17. Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol. 2004;22:19–22
  18. Ang KK, Harris J, Garden AS, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation therapy oncology group phase II trial 99-14. J Clin Oncol. 2005;23:3008–3015
  19. Machtay M, Moughan J, Trotti A, et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin ncol. 2008;26:3582–3589
  20. Staar S, Rudat V, Stuetzer H, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—Results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:1161–1171
  21. Ang KK. Multidisciplinary management of locally advanced SCCHN: Optimizing treatment outcomes. Oncologist. 2008;13:899–910
  22. Bentzen SM. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702–713
  23. Bernier J, Bentzen SM. Radiotherapy for head and neck cancer: Latest developments and future perspectives. Curr Opin Oncol. 2006;18:240–246
  24. Bourhis J. New approaches to enhance chemotherapy in SCCHN. Ann Oncol. 2005;16(Suppl. 6):vi20–vi24
  25. Thariat J, Milas L, Ang KK. Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69:974–984
  26. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567–578
  27. Bentzen SM, Atasoy BM, Daley FM, et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol. 2005;23:5560–5567

 Funding was provided by the Cancer Research Campaign UK and the Marie Curie Research Translational Research Fund.

 Conflict of interest: none.

PII: S0360-3016(09)00724-X

doi: 10.1016/j.ijrobp.2009.04.082

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 3-8 , 1 May 2010

Article Tools

* Image Usage & Resolution